These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6939909

  • 1. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE, Socquet M, Delforge A, Stryckmans P.
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [Abstract] [Full Text] [Related]

  • 2. In vitro drug sensitivity studies of colony-forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic-phase patients and normal donors.
    Kirshner J, Preisler HD.
    Cancer Res; 1983 Dec; 43(12 Pt 1):6094-5. PubMed ID: 6580067
    [Abstract] [Full Text] [Related]

  • 3. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR, Meyskens FL, Moon TE, Durie BG, Salmon SE.
    Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
    [Abstract] [Full Text] [Related]

  • 4. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia.
    Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF.
    Nature; 1982 Nov; 328(6128):342-4. PubMed ID: 3474529
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
    Spiro TE, Mattelaer MA, Efira A, Stryckmans P.
    J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
    [Abstract] [Full Text] [Related]

  • 6. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
    Dowding CR, Gordon MY, Goldman JM.
    Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
    [Abstract] [Full Text] [Related]

  • 7. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M, Nagler A, Lishner M, Amiel A, Yarkoni S, Rudi A, Gellerman G, Kashman Y, Fabian I.
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [Abstract] [Full Text] [Related]

  • 8. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil.
    Reiner P, Mardiak J, Reinerová M, Ujházy V.
    Neoplasma; 1981 Jun; 28(5):533-9. PubMed ID: 6947140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B, Pasternak G, Hehlmann R.
    Folia Biol (Praha); 2000 Jun; 46(6):256-63. PubMed ID: 11140859
    [Abstract] [Full Text] [Related]

  • 15. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 16. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE.
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [Abstract] [Full Text] [Related]

  • 17. Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L).
    Linssen P, Brons P, Knops G, Wessels H, de Witte T.
    Eur J Haematol; 1993 Mar; 50(3):149-54. PubMed ID: 8472810
    [Abstract] [Full Text] [Related]

  • 18. Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow.
    Andersson BS, Wang YQ, McCredie KB, Farquhar D.
    Leukemia; 1990 Jun; 4(6):435-40. PubMed ID: 2359343
    [Abstract] [Full Text] [Related]

  • 19. Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay.
    Swart K, Hagemeijer A, Löwenberg B.
    Exp Hematol; 1981 Jul; 9(6):588-94. PubMed ID: 6943037
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.